Table 1 Clinical data between Alzheimer’s disease (AD) patients and age-matched controls.

From: Cerebral Perfusion Insufficiency and Relationships with Cognitive Deficits in Alzheimer’s Disease: A Multiparametric Neuroimaging Study

 

AD (n = 50)

Control (n = 30)

Age (years)

73.32(8.40)

71.03(8.05)

Education (years)

5.3(4.51)*

8.5(5.22)

Gender (female, %)

33(66%)

18(60%)

Diabetes Mellitus, cases (%)

9(18%)

6 (20%)

Hypertension, cases (%)

29(58%)

17(56.7%)

APOE4 carrier, cases (%)

27(54%)*

6(20%)

High sensitivity C- reactive protein (mg/L)

2.94(3.53)

1.72(1.61)

Creatinine (mg%)

0.90(0.26)

0.91(0.25)

Total cholesterol (mg/dl)

195(37.8)

180(29.0)

Triglyceride (mg/dl)

116(59.4)

109(47.2)

High-density lipoprotein (mg/dl)

57.3(13.3)

55.7(16.7)

Low-density lipoprotein (mg/dl)

112(30.2)

104(29.3)

Mini-Mental State Examination

16.78(5.13)*

27.07(1.91)

CASI total scores

56.46(17.61)*

85.81(6.00)

   Mental manipulation

4.4(3.16)*

8.4(1.59)

   Attention

5.8(1.41)*

6.9(0.92)

   Orientation

10.6(4.56)*

17.1(2.26)

   Long term memory

7.4(2.75)*

9.6(0.81)

   Short term memory

3.0(2.08)*

8.9(1.51)

   Abstract thinking

6.8(2.40)*

9.1(1.63)

   Drawing

6.3(3.42)*

9.3(1.06)

   Language Composite scores

11.5(4.73)*

16.5(2.43)

Cerebral blood flow(ml/100 g/min)

   Global

40.4(9.76)*

47.1(7.13)

   Frontal cortex

44.6(10.4)*

50.6(7.01)

   Lateral temporal regions of interest

42.5(7.54)*

49.0(6.97)

   Medial temporal cortex

40.0(9.23)*

43.8(5.29)

   Occipital cortex

34.0(10.1)*

43.2(9.23)

   Parietal cortex

37.9(10.7)*

46.2(8.61)

  1. Data are presented as mean (standard deviation) or the number (frequency, %); *p < 0.01.
  2. Abbreviations: CASI, Cognitive Abilities Screening Instrument; APOE4, Apolipoprotein E4.
  3. Medial temporal cortex = hippocampus, para-hippocampus and amygdala.
  4. Lateral temporal regions of interest = superior, middle and inferior temporal areas, and the superior and middle temporal pole areas.